ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on the science ...

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the ...

identified treatments that could be studied in clinical trials for the condition based on their potential to lower levels of ...

By incorporating healthspan science into clinical practice, some doctors are navigating a gray area between mainstream ...

LOS ANGELES, March 20, 2025--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy ...

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid withdrawal (TSW) is distinct from eczema and is caused by an excess of an ...

This study is reported by Lizeng Gao's group from the Institute of Biophysics, Chinese Academy of Sciences, Beijing. The ...

That process, called carbon fixation, resulted in the assembly of two three-carbon molecules called 3-phosphoglycerate (3-PGA ...

ChromaDex Corp. (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. The ChromaDex team, composed of world-renowned ...

NAD infusions are just one of the latest crazes for longevity-seekers, but can it really help you live longer? Here’s what an ...

Australian-born Harvard geneticist David Sinclair says reversing the symptoms of ageing in animals and humans is now possible ...